Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

Regeneron Gains Cancer, Infectious Disease Immunotherapies

Regeneron lab

A biotechnology company is licensing five of its vaccines for cancer and infectious diseases to Regeneron Pharmaceuticals in a deal valued at nearly $1 billion. . . . → Read More: Regeneron Gains Cancer, Infectious Disease Immunotherapies

New Company to Develop Synthetic Antibody Therapies

SARS-CoV-2 particle

A new business is underway to develop and commercialize treatments for Covid-19 and other diseases based on synthetic antibody proteins. . . . → Read More: New Company to Develop Synthetic Antibody Therapies

Joint Venture to Develop Stable RNA Covid-19 Vaccine

Shark

A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine. . . . → Read More: Joint Venture to Develop Stable RNA Covid-19 Vaccine

Crispr Licensed for Eye Disease Gene Therapies

Retinal gene therapy

A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes. . . . → Read More: Crispr Licensed for Eye Disease Gene Therapies

Precision Neuroscience Company Starts-Up, Raises $500M

Brain activity graphic

A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science. . . . → Read More: Precision Neuroscience Company Starts-Up, Raises $500M

Gene Therapy Delivery Company Gains $26M in Early Funds

DNA puzzle

A developer of delivery methods for gene therapies promising greater safety for patients is raising $26 million in its first venture funding round. . . . → Read More: Gene Therapy Delivery Company Gains $26M in Early Funds

Delivery Tech Licensed for CBD Epilepsy Nasal Spray

Blooming cannibis plant

A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray

FDA Okays One-Time HIV Treatment Clinical Trial

HIV released from cell

A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial. . . . → Read More: FDA Okays One-Time HIV Treatment Clinical Trial

Pharma, Synthetic Bio Companies to Find Antibody Therapies

DNA chip graphic

A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases. . . . → Read More: Pharma, Synthetic Bio Companies to Find Antibody Therapies

Biotech Start-Up Gains $90M for Neurodegenerative Diseases

Mature neuron

A one year-old biotechnology company developing treatments for diseases of microglia cells in the brain, is raising $90 million in new venture funds. . . . → Read More: Biotech Start-Up Gains $90M for Neurodegenerative Diseases